Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892339) titled 'Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study' on Oct. 17.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Cairo University
Condition:
Psoriasis
Psoriasis Genital
Intervention:
Drug: Crisaborole 2% topical ointment
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 25, 2026
Target Sample Size: 40
Countries o...